Last, because it is known that CD4+ T cells are necessary for regulating the magnitude and quality of the cytotoxic CD8+ T cell response, we investigated the molecular mechanisms by which TRM17 might regulate the CD8+ T cell cytotoxic response in patients with COVID-19. The gene discussed is CD8A; the disease is COVID-19.